Literature DB >> 10518929

Molecular cloning of mXCR1, the murine SCM-1/lymphotactin receptor.

T Yoshida1, D Izawa, T Nakayama, K Nakahara, M Kakizaki, T Imai, R Suzuki, M Miyasaka, O Yoshie.   

Abstract

Single C motif-1 (SCM-1)/lymphotactin is a C-type member of the chemokine superfamily. Previously, we identified its specific receptor XCR1. Here we isolated the murine homologue of XCR1 (mXCR1). To demonstrate its biological activity, we produced recombinant mouse SCM-1 by the baculovirus expression system. B300-19 murine pre-B cells expressing mXCR1 responded to mSCM-1 in chemotactic and calcium-mobilization assays. mXCR1 mRNA was weakly expressed in spleen and lung of normal C57BL/6 mice. In spleen, CD8+ cells and NK1.1+ cells were found to express mXCR1. Identification of mXCR1 will now allow us to study the role of this unique cytokine system in the mouse models of inflammation and immunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518929     DOI: 10.1016/s0014-5793(99)01114-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease.

Authors:  P Middel; P Thelen; S Blaschke; F Polzien; K Reich; V Blaschke; A Wrede; K M Hummel; B Gunawan; H J Radzun
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Expressions of lymphotactin and its receptor, XCR, in Lewis rats with experimental autoimmune anterior uveitis.

Authors:  Po-Ting Yeh; Feng-An Lin; Chang-Pin Lin; Chung-May Yang; Muh-Shy Chen; Chang-Hao Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-29       Impact factor: 3.117

3.  A parenteral DNA vaccine protects against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Xinghong Yang; Richard Bowen; Sarah Golden; Kathryn Crist; Todd Becker; Massimo Maddaloni; David W Pascual
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

Review 4.  Role of chemokines and chemokine receptors in the gastrointestinal tract.

Authors:  Maureen N Ajuebor; Mark G Swain
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

5.  MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.

Authors:  Brigitte G Dorner; Alexander Scheffold; Michael S Rolph; Martin B Huser; Stefan H E Kaufmann; Andreas Radbruch; Inge E A Flesch; Richard A Kroczek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

6.  Lymphotactin enhances the in-vitro immune efficacy of dendritoma formed by dendritic cells and mouse hepatocellular carcinoma cells.

Authors:  Hao Zhang; Guo-ping Jiang; Shu-sen Zheng; Li-hua Wu; Feng Zhu; Zhen-lin Yang
Journal:  J Zhejiang Univ Sci       Date:  2004-10

Review 7.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

Review 8.  Recent Progress in Dendritic Cell-Based Cancer Immunotherapy.

Authors:  Kazuhiko Matsuo; Osamu Yoshie; Kosuke Kitahata; Momo Kamei; Yuta Hara; Takashi Nakayama
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

9.  The Role of XCR1 and its Ligand XCL1 in Antigen Cross-Presentation by Murine and Human Dendritic Cells.

Authors:  Richard A Kroczek; Volker Henn
Journal:  Front Immunol       Date:  2012-02-10       Impact factor: 7.561

10.  RANKL-induced DC-STAMP is essential for osteoclastogenesis.

Authors:  Toshio Kukita; Naohisa Wada; Akiko Kukita; Takashi Kakimoto; Ferry Sandra; Kazuko Toh; Kengo Nagata; Tadahiko Iijima; Madoka Horiuchi; Hiromi Matsusaki; Kunio Hieshima; Osamu Yoshie; Hisayuki Nomiyama
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.